Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients
Open accessThe DOI matches its Crossref record.
Abstract
Malignant pleural mesothelioma (MPM) is an asbestos‐related malignancy that is highly resistant to current therapeutic modalities. We established four MPM cell lines (ACC‐MESO‐1, ACC‐MESO‐4, Y‐MESO‐8A and Y‐MESO‐8D) from Japanese patients, with the latter two from the same patient with biphasic‐like characteristics of MPM, showing epithelial and sarcomatous phenotypes, respectively, in cell culture. These cells grew well in RPMI‐1640 medium supplemented with 10% fetal bovine serum under 5% CO 2. Mutation and expression analyses demonstrated that the tumor suppressor gene NF2, which is known to be one of the most frequently mutated in MPM, is mutated in ACC‐MESO‐1. We detected homozygous deletion of p16INK4A/p14ARF in all four MPM cell lines. However, mutations of other tumor suppressor genes, including TP53, and protooncogenes, including KRAS, NRAS, BRAF, EGFR and HER2, were not found in these cell lines. Polymerase chain reaction amplification of the simian virus 40 sequence did not detect any products. We also analyzed genetic alterations of six other MPM cell lines and confirmed frequent mutations of NF2 and p16INK4A/p14ARF. To characterize the biological differences between Y‐MESO‐8A and Y‐MESO‐8D, we carried out cDNA microarray analysis and detected genes that were differentially expressed in these two cell lines. Thus, our new MPM cell lines seem to be useful as new models for studying various aspects of the biology of human MPM as well as materials for the development of future therapies. (Cancer Sci 2006; 97)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma
Murakami, H., Mizuno, T., Taniguchi, T., Fujii, M., Ishiguro, F., Fukui, T., Akatsuka, S., Horio, Y., Hida, T., Kondo, Y., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2164 · Cited by 263
Self-citationAung, W., Hasegawa, S., Furukawa, T., & Saga, T. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm090 · Cited by 62
Ohara, Y., Chew, S. H., Misawa, N., Wang, S., Somiya, D., Nakamura, K., Kajiyama, H., Kikkawa, F., Tsuyuki, Y., Jiang, L., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24892 · Cited by 44
“Six Japanese mesothelioma cell lines, ACC-MESO-1, ACC-MESO-4, Y-MESO-8A, Y-MESO-8D, Y-MESO-9 and Y-MESO-12, were established by Yoshitaka Sekido (Aichi Cancer Center Research Institute, Nagoya, Japan) [54, 55].”
Self-citationJiang, L., Yamashita, Y., Chew, S., Akatsuka, S., Ukai, S., Wang, S., Nagai, H., Okazaki, Y., Takahashi, T., & Toyokuni, S. (2014) · The Journal of Pathology · doi:10.1002/path.4377 · Cited by 34
Jiang, L., Chew, S., Nakamura, K., Ohara, Y., Akatsuka, S., & Toyokuni, S. (2016) · Cancer Science · doi:10.1111/cas.12947 · Cited by 19
Metadata
- Authors
- Usami, N., Fukui, T., Kondo, M., Taniguchi, T., Yokoyama, T., Mori, S., Yokoi, K., Horio, Y., Shimokata, K., Sekido, Y., & Hida, T.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2006-03-13
- Volume
- 97
- Issue
- 5
- Pages
- 387-394
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W1971170437
- Cited by
- 133
- References
- 0
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients. https://app.cochat.ai/papers/10.1111/j.1349-7006.2006.00184.x
- The paper
- Usami, N., Fukui, T., Kondo, M., Taniguchi, T., Yokoyama, T., Mori, S., Yokoi, K., Horio, Y., Shimokata, K., Sekido, Y., & Hida, T. (2006). Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients. Cancer Science. https://doi.org/10.1111/j.1349-7006.2006.00184.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.